Document ID: chunk:federal_register_of_legislation:F2025C00119:reg:32
Version: federal_register_of_legislation:F2025C00119
Segment Type: reg
Provision Reference: reg 32
Character Range: 50806–52144

32  Mark‑up for a chemotherapy pharmaceutical benefit
 (1) For the purposes of paragraph 31(4)(b), the mark‑up for a chemotherapy pharmaceutical benefit is:

  where:
mark‑up for maximum units means the amount worked out:
 (a) if the chemotherapy pharmaceutical benefit does not have trastuzumab—under subsection (2); or
 (b) if the chemotherapy pharmaceutical benefit has trastuzumab—under subsection (3).
maximum units of pharmaceutical benefit is the whole number of units of the chemotherapy pharmaceutical benefit required to obtain the maximum amount of the chemotherapy drug in the benefit that is determined by section 14.
 (2) The following table sets out how to work out the mark‑up for maximum units for a chemotherapy pharmaceutical benefit that does not have trastuzumab.

Mark‑up for pharmaceutical benefit that does not have trastuzumab
Item                                                               Column 1                                                                        Column 2

                                                                   If the maximum units ex‑manufacturer price for the pharmaceutical benefit is …

                                                                                                                                                   the mark‑up for maximum units is …